Table 4.

Outcome of treatment of patients with acute megakaryocytic leukemia

PatientResponse to induction therapyRemission duration (mo)Survival (mo)Cause of induction failureCurrent status
CR 21  Deceased 
NR  AMegL Deceased 
CR 19 24  Deceased 
CR 10  Deceased 
NR  AMegL Deceased 
NR  Sepsis Deceased 
CR 15 22+  Alive 
CR 15  Deceased 
CR  Deceased 
10 CR 160+ 160+  Alive 
11 NR  AMegL Deceased 
12 NR  Respiratory failure Deceased 
13 NR  11 AMegL Deceased 
14 NR  Probable infection Deceased 
15 CR 12 30  Deceased 
16 CR  Deceased 
17 NR  37 AMegL Deceased 
18 NR  10 AMegL Deceased 
19 CR 10  Deceased 
20 NR  10 AMegL Deceased 
PatientResponse to induction therapyRemission duration (mo)Survival (mo)Cause of induction failureCurrent status
CR 21  Deceased 
NR  AMegL Deceased 
CR 19 24  Deceased 
CR 10  Deceased 
NR  AMegL Deceased 
NR  Sepsis Deceased 
CR 15 22+  Alive 
CR 15  Deceased 
CR  Deceased 
10 CR 160+ 160+  Alive 
11 NR  AMegL Deceased 
12 NR  Respiratory failure Deceased 
13 NR  11 AMegL Deceased 
14 NR  Probable infection Deceased 
15 CR 12 30  Deceased 
16 CR  Deceased 
17 NR  37 AMegL Deceased 
18 NR  10 AMegL Deceased 
19 CR 10  Deceased 
20 NR  10 AMegL Deceased 

CR = complete remission; NR = no response or lack of complete remission; AMegL = acute megakaryocytic leukemia.

or Create an Account

Close Modal
Close Modal